The role of the endocannabinoid system in the regulation of energy expenditure

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 23, Issue 1, 2009, Pages 79-86

  Cavuoto, Paul ^a   Wittert, Gary A ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

2 arachidonyl glycerol; anandamide; CB1; endocannabinoid; energy expenditure; metabolism

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; FATTY ACID; GLUCOSE; LIPID; MITOCHONDRIAL DNA; RIMONABANT; VANILLOID RECEPTOR 1;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DNA SYNTHESIS INHIBITION; DRUG RECEPTOR BINDING; ENERGY CONSUMPTION; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID OXIDATION; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; METABOLIC REGULATION; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; EATING; ENDOCANNABINOIDS; ENERGY METABOLISM; HUMANS; INTESTINAL ABSORPTION; LEPTIN; LIVER; MUSCLE, SKELETAL; OBESITY; PANCREAS; RECEPTOR, CANNABINOID, CB1; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 61649087444     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2008.10.005     Document Type: Review

References (49)

1. Cota D., Marsicano G., Tschop M., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation 112 3 (2003) 423-431
2. Ravinet Trillou C., Delgorge C., Menet C., et al. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. International Journal of Obesity and Related Metabolic Disorders 28 4 (2004) 640-648
3. Kunz I., Meier M.K., Bourson A., et al. Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats. International Journal of Obesity (London) 32 5 (2008) 863-870
4. Herling A.W., Kilp S., Elvert R., et al. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Endocrinology 149 5 (2008) 2557-2566
5. Bensaid M., Gary-Bobo M., Esclangon A., et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular Pharmacology 63 4 (2003) 908-914
6. Osei-Hyiaman D., DePetrillo M., Pacher P., et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation 115 5 (2005) 1298-1305
7. Matias I., Gonthier M.P., Orlando P., et al. Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and {beta}-Pancreatic Cells and in Obesity and Hyperglycemia. Journal of Clinical Endocrinology and Metabolism 91 8 (2006) 3171-3180
8. Pagotto U., Marsicano G., Cota D., et al. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews 27 1 (2006) 73-100
9. Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut 48 6 (2001) 859-867
10. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 6704 (1998) 763-770
11. Di Marzo V., Goparaju S.K., Wang L., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 6830 (2001) 822-825
12. Jo Y.H., Chen Y.J., Chua Jr. S.C., et al. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48 6 (2005) 1055-1066
13. Preston E., Triandafillou J., and Haas N. Colchicine lesions of ventromedial hypothalamus: effects on regulatory thermogenesis in the rat. Pharmacology, Biochemistry, and Behavior 32 1 (1989) 301-307
14. Bingham N.C., Anderson K.K., Reuter A.L., et al. Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 149 5 (2008) 2138-2148
15. Dhillon H., Zigman J.M., Ye C., et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49 2 (2006) 191-203
16. Esfandyari T., Camilleri M., Ferber I., et al. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterology and Motility 18 9 (2006) 831-838
17. Coutts A.A., and Pertwee R.G. Evidence that cannabinoid-induced inhibition of electrically evoked contractions of the myenteric plexus-longitudinal muscle preparation of guinea-pig small intestine can be modulated by Ca2+ and cAMP. Canadian Journal of Physiology and Pharmacology 76 3 (1998) 340-346
18. Izzo A.A., Mascolo N., Pinto L., et al. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. European Journal of Pharmacology 384 1 (1999) 37-42
19. Di Marzo V., Capasso R., Matias I., et al. The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. British Journal of Pharmacology 153 6 (2008) 1272-1280
20. Gomez R., Navarro M., Ferrer B., et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. Journal of Neuroscience 22 21 (2002) 9612-9617
21. Yuece B., Sibaev A., Broedl U.C., et al. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex. Neurogastroenterology and Motility 19 9 (2007) 744-753
22. Gary-Bobo M., Elachouri G., Gallas J.F., et al. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46 1 (2007) 122-129
23. Nakata M., and Yada T. Cannabinoids inhibit insulin secretion and cytosolic Ca(2+) oscillation in islet beta-cells via CB1 receptors. Regulatory Peptides 145 (2008) 49-53
24. Starowicz K.M., Cristino L., Matias I., et al. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 16 3 (2008) 553-565
25. Juan-Pico P., Fuentes E., Bermudez-Silva F.J., et al. Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. Cell Calcium 39 2 (2006) 155-162
26. Bermudez-Silva F.J., Sanchez-Vera I., Suarez J., et al. Role of cannabinoid CB2 receptors in glucose homeostasis in rats. European Journal of Pharmacology 565 1-3 (2007) 207-211
27. Tharp W.G., Lee Y.H., Maple R., et al. The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochemical and Biophysical Research Communications 372 4 (2008) 595-600
28. Yan Z.C., Liu D.Y., Zhang L.L., et al. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochemical and Biophysical Research Communications 354 2 (2007) 427-433
29. Jbilo O., Ravinet-Trillou C., Arnone M., et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB Journal 19 11 (2005) 1567-1569
30. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 8 11 (2002) 1288-1295
31. Lihn A.S., Jessen N., Pedersen S.B., et al. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochemical and Biophysical Research Communications 316 3 (2004) 853-858
32. Kola B., Hubina E., Tucci S.A., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. Journal of Biological Chemistry 280 26 (2005) 25196-25201
33. Motaghedi R., and McGraw T.E. The CB1 Endocannabinoid System Modulates Adipocyte Insulin Sensitivity. Obesity (Silver Spring) 16 8 (2008) 1727-1734
34. Kempf K., Hector J., Strate T., et al. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity. Hormone and Metabolic Research 39 8 (2007) 596-600
35. Tedesco L., Valerio A., Cervino C., et al. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through eNOS expression in white adipocytes. Diabetes 57 8 (2008) 2028-2036
36. Zhou D., and Shearman L.P. Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice. Pharmacology, Biochemistry, and Behavior 77 1 (2004) 117-125
37. Roche R., Hoareau L., Bes-Houtmann S., et al. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochemistry and Cell Biology 126 (2006) 177-187
38. Zurlo F., Larson K., Bogardus C., et al. Skeletal muscle metabolism is a major determinant of resting energy expenditure. Journal of Clinical Investigation 86 5 (1990) 1423-1427
39. Cavuoto P., McAinch A.J., Hatzinikolas G., et al. The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochemical and Biophysical Research Communications 364 1 (2007) 105-110
40. Liu Y.L., Connoley I.P., Wilson C.A., et al. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. International Journal of Obesity and Related Metabolic Disorders 29 2 (2005) 183-187
41. Cavuoto P., McAinch A.J., Hatzinikolas G., et al. Effects of Cannabinoid Receptors on Skeletal Muscle Oxidative Pathways. Molecular and Cellular Endocrinology 267 1-2 (2007) 63-69
42. Newman Z., Malik P., Wu T.Y., et al. Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction. European Journal of Neuroscience 25 6 (2007) 1619-1630
43. Matias I., Petrosino S., Racioppi A., et al. Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Molecular and Cellular Endocrinology (2008) 286 [Note(s): S66-S78]
44. Engeli S., Bohnke J., Feldpausch M., et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54 10 (2005) 2838-2843
45. Evans D.J., Murray R., and Kissebah A.H. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. Journal of Clinical Investigation 74 4 (1984) 1515-1525
46. Lonnqvist F., Nordfors L., Jansson M., et al. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. Journal of Clinical Investigation 99 10 (1997) 2398-2404
47. Kelley D.E., Goodpaster B., Wing R.R., et al. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. American Journal of Physiology. Endocrinology and Metabolism 277 6 Pt 1 (1999) 1130-1141
48. D'Eon T.M., Pierce K.A., Roix J.J., et al. The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 57 5 (2008) 1262-1268
49. Buettner C., Muse E.D., Cheng A., et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nature Medicine 14 6 (2008) 667-675